Development of Substance Use Problems: The Role of Adolescent Cannabis Age of Onset, Frequency of Use and Childhood Risk Factors
- PMID: 41483051
- DOI: 10.1007/s10802-025-01404-z
Development of Substance Use Problems: The Role of Adolescent Cannabis Age of Onset, Frequency of Use and Childhood Risk Factors
Abstract
Substance use (SU) problems are critical public health concerns. This study investigated how childhood risk factors and cannabis age of onset (CAO) in adolescence predict later SU problems, using data from the two cohorts of the Quebec Longitudinal Study of Child Development (N = 306; 57% female; N = 1489; 54% female), followed from birth to age 23. A direct association between early CAO and increased cannabis use problems was found in males (cohort 1: β = -0.47; cohort 2: β = -0.22), but not in females. In both sexes, CAO was indirectly associated with later cannabis use problems via increased adolescent cannabis use frequency (cohort 1: ab = -0.41; cohort 2: ab = -0.35). Similar indirect associations were observed between CAO and other SU problems (including tobacco and alcohol), via adolescent cannabis use frequency (cohort 1: ab = -2.63). Parental cannabis use, adverse childhood experiences, and childhood externalizing behaviors (i.e., physical aggression and ADHD symptoms) were associated with early CAO and subsequent CU problems. These findings support developmental models linking early risk exposures to maladaptive substance use pathways and underscore the importance of prevention strategies targeting early cannabis initiation and modifiable early-life risk factors to reduce long-term SU-related problems.
Keywords: Cannabis age of onset; Cannabis use problems; Childhood risk factors; Prospective study.; Sex differences; Substance use problems.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval : The QLSCD protocol was approved by the Institut de la statistique du Québec and the St-Justine Hospital Research Centre ethics committees in accordance with the Declaration of Helsinki, and informed assent and consent was acquired at each data collection. Patient consent statement: Written informed consent was obtained from all participants or their legal guardians. All identifying details have been removed to maintain confidentiality. Competing interests: None to declare.
References
-
- Agrawal, A., & Lynskey, M. T. (2014). Cannabis controversies: How genetics can inform the study of comorbidity. Addiction, 109(3), 360–370. https://doi.org/10.1111/add.12436 - DOI - PubMed - PMC
-
- Behrendt, S. (2017). The Role of Age in the Onset and Further Development of Cannabis Use Disorders. Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (pp. 138–150). https://doi.org/10.1016/B978-0-12-800756-3.00016-8
-
- Behrendt, S., Wittchen, H. U., Höfler, M., Lieb, R., & Beesdo, K. (2009). Transitions from first substance use to substance use disorders in adolescence: Is early onset associated with a rapid escalation? Drug and Alcohol Dependence, 99(1–3), 68–78. https://doi.org/10.1016/j.drugalcdep.2008.06.014 - DOI - PubMed
-
- Behrendt, S., Beesdo-Baum, K., Höfler, M., Perkonigg, A., Bühringer, G., Lieb, R., & Wittchen, H. U. (2012). The relevance of age at first alcohol and nicotine use for initiation of cannabis use and progression to cannabis use disorders. Drug and Alcohol Dependence, 123(1–3), 48–56. https://doi.org/10.1016/j.drugalcdep.2011.10.013 - DOI - PubMed
-
- Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x - DOI